# Clomiphene

## Clomiphene 50mg (PEILI)

| TAH Drug Code      | [OCLOM5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCLOM5)                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Induction of ovulation for infertility caused by ovulatory disorders.                                                                                                                                                                                                                                                                                                         |
| Dosing             | Female infertility due to ovulatory disorder: 50 mg orally daily for 5 days starting on the 5th day of menstrual cycle or at any time if no recent uterine bleeding; if ovulation has not occurred, 100 mg (single daily dose) for 5 days can be initiated next menstrual cycle. Discontinue medication if no ovulatory menstruation occurs after three cycles.               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | No Data                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common: Flushing, Vasomotor (10.4%), Abdominal bloating, Abdominal discomfort, Nausea and vomiting, Swollen abdomen, Headache (1.3%), Visual disturbance (1.5%), Pain of breast (2.1%). Serious: Pancreatitis, acute, Functional visual loss, Psychotic disorder, Disorder of menstruation (1.3%), Hyperstimulation of ovaries, Hypertrophy of ovary (13.6%), Ovarian cancer. |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/clomiphene-drug-information)                                                                                                                                                                                                                                                                                                     |

